Abiopharma

🔍 Gupta Ashwini (Director)

Company: ENCORE CAPITAL GROUP INC (ECPG)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 291 shares of Common Stock at $93.01 per share (Direct)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 105,927.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Grant to the reporting person, for service on the Board of Directors of Encore Capital Group, Inc. ("Encore"), of deferred stock units under the terms of a non-employee director deferred compensation plan established under the 2017 Incentive Award Plan. Deferred stock units will be converted into shares of Encore common stock on a one-for-one basis upon distribution. The distribution of shares of common stock will occur within 10 business days following the fifth anniversary of the date the reporting person is no longer a member of the Board of Directors.